Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Blood (2022) 139 (15): 2306–2315.
Currently there are no citedby results. Try again later.

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals